The UK Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme collects reports of suspected side effects or negatives reactions to drugs. Concerning GLP-1’s, it received almost 400 reports of serious pancreas trouble – and about 10 deaths linked to this. Unilad had an advance look.


